Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Cristian Suarez-Cabrera
Cdk4/6-Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of RB1 Status
Clinical Cancer Research
Cancer Research
Oncology
Correction: Protective Role of P53 in Skin Cancer: Carcinogenesis Studies in Mice Lacking Epidermal P53
Oncotarget
Oncology
Related publications
Kinase Inhibitor Screening Identifies CDK4 as a Potential Therapeutic Target for Melanoma
International Journal of Oncology
Cancer Research
Oncology
Palbociclib: First CDK4/6 Inhibitor in Clinical Practice for the Treatment of Advanced HR-Positive Breast Cancer
Breast Care
Surgery
Oncology
A Novel Tankyrase Inhibitor, MSC2504877, Enhances the Effects of Clinical CDK4/6 Inhibitors
Scientific Reports
Multidisciplinary
Preclinical Characterization of G1T28: A Novel CDK4/6 Inhibitor for Reduction of Chemotherapy-Induced Myelosuppression
Molecular Cancer Therapeutics
Cancer Research
Oncology
CDK4/6 Inhibitors resTORe Therapeutic Sensitivity in HER2 + Breast Cancer
Cancer Cell
Cancer Research
Oncology
Cell Biology
A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing Sarcoma
Clinical Cancer Research
Cancer Research
Oncology
P16 Methylation Increases the Sensitivity of Cancer Cells to the CDK4/6 Inhibitor Palbociclib
PLoS ONE
Multidisciplinary
P16 Methylation Increases the Sensitivity of Cancer Cells to the CDK4/6 Inhibitor Palbociclib
Management of Adverse Events During Cyclin-Dependent Kinase 4/6 (CDK4/6) Inhibitor-Based Treatment in Breast Cancer
Therapeutic Advances in Medical Oncology
Oncology
